Another Warning Letter … and we still miss software validation

Glanced through the latest FDA warning letters today.  From the FDA Medical Device & Radiological Health Operations West/Division 3 I see the inspector pointing out “This design validation also fails to include software validation [emphasis mine] to assure software will perform as intended and will not prevent safe operation by the user.”   Of course this is straight from the regs – 21CFR820.30(g). Absolutely one must consider the safe and effective operation of the software when making an argument for design validation.  For those of us familiar with software development, we are always skeptical our software will perform as expected under all operating conditions.

So what does FDA expect with regard to software validation?  A common misconception is that software validation is a very comprehensive test that is executed once the final version of software is created. While a comprehensive test is helpful, testing alone is insufficient to give confidence that software is performing according to all specs, meets the users’ expectations, and that defects will not lead to hazardous situations. FDA guidance recommends, and fully expects, an entire software development lifecycle approach to software quality.  Safe and effective software, at a minimum, should include:

  • designed-in risk control measures
  • other operating self checks of hardware and software

Additionally, the software should be developed under appropriate and sufficient process controls throughout the entire lifecycle.  IEC 62304 is an FDA recognized standard for software development process and IEC 80002-1 contains many excellent best practices for medical device software. These two standards are definitely a good start for ensuring the software development lifecycle process being used is state-of-the-art.

Beyond FDA expectations or requirements under ISO standards, each company should develop their own quality standards – remember published standards like IEC 62304 are meant to be the “bar” which in reality is a minimum.  Our goal as software professionals is to create defect-free designs. Go beyond the bar.  Focus on “real” quality – develop appropriate metrics so that it is clear where the process works well and where it is not working well.  As one professional stated, “Own it. Take responsibility for software errors and make the changes necessary to prevent inserting others.

About the author

Brian is a biomedical software engineer - whatever that is! Started writing machine code for the Intel 8080 in 1983. Still enjoys designing and developing code. But probably enjoys his garden more now and watching plants grow ... and grandkids grow!

SoftwareCPR Training Courses:

IEC 62304 and other emerging standards for Medical Device and HealthIT Software

Our flagship course for preparing regulatory, quality, engineering, operations, and others for the activities and documentation expected for IEC 62304 conformance and for FDA expectations. The goal is to educate on the intent and purpose so that the participants are able to make informed decisions in the future.  Focus is not simply what the standard says, but what is meant and discuss examples and approaches one might implement to comply.  Special deep discount pricing available to FDA attendees and other regulators.

3-days onsite with group exercises, quizzes, examples, Q&A.

Instructor: Brian Pate

Next public offering:  TBD

Email training@softwarecpr.com to request a special pre-registration discount.  Limited number of pre-registration coupons.

Registration Link:

TBD

 


 

Being Agile & Yet Compliant (Public or Private)

Our SoftwareCPR unique approach to incorporating agile and lean engineering to your medical device software process training course is now open for scheduling!

  • Agile principles that align well with medical
  • Backlog management
  • Agile risk management
  • Incremental and iterative software development lifecycle management
  •  Frequent release management
  • And more!

2-days onsite (4 days virtual) with group exercises, quizzes, examples, Q&A.

Instructors: Mike Russell, Ron Baerg

Next public offering: March 7 & 28, 2024

Virtual via Zoom

Registration Link:

Register Now

 


 

Medical Device Cybersecurity (Public or Private)

This course takes a deep dive into the US FDA expectations for cybersecurity activities in the product development process with central focus on the cybersecurity risk analysis process. Overall approach will be tied to relevant standards and FDA guidance documentation. The course will follow the ISO 14971:2019 framework for overall structure but utilize IEC 62304, IEC 81001-5-1, and AAMI TIR57 for specific details regarding cybersecurity planning, risk characterization, threat modeling, and control strategies.

2-days onsite with group exercises, quizzes, examples, Q&A.

Instructor: Dr Peter Rech, 2nd instructor (optional)

Next public offering:  TBD

Corporate Office

15148 Springview St.
Tampa, FL 33624
USA
+1-781-721-2921
Partners located in the US (CA, FL, MA, MN, TX) and Canada.